This is GHK-Cu
related full-length recombinant thymosin beta-4 (a different formulation than the marketed TB-500 fragment) has also been examined in small human studies for cardiac and dermatologic indications Examined in preclinical models, including diabetic rat Achilles tendon and rat ligament-injury studies, for actin-binding, cell-migration, and angiogenic activity that researchers have proposed as a mechanism for tendon and ligament repair, though this literature remains comparatively sparse for musculoskeletal applications specifically Known risks and side effects: Because TB-500 is manufactured and sold without FDA oversight as a "research chemical," independent testing and industry reporting describe wide variability in purity (with some products measured well below labeled potency) and contamination with heavy metals or bacterial byproducts, unlike pharmaceutical-grade recombinant thymosin beta-4 used in registered clinical trials Thymosin beta-4's core mechanisms, angiogenesis and cell migration, are also pathways exploited by tumors
60 HP 95 DSIP Delta Sleep-Inducing Peptide ALIASES DSIP, delta sleep-inducing peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu CLASS Endogenous nonapeptide sleep / stress-pathway modulator FORMULA C35H48N10O15 SEQUENCE Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu HALF-LIFE Very short (minutes) plasma longer CNS retention reported ROUTES Subcutaneous (research) Intranasal (research) MECHANISM OF ACTION Nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from rabbit cerebral venous blood during electrically induced sleep states
Various methods of delivery are being investigated for use with this peptide
People who experience significant nausea on GLP-1 receptor agonists may tolerate tirzepatide with B12 better than formulations without it
A Missouri woman who was taking products from Blome Research told KSN 16 she feels betrayed and that she is not planning on using their products again
.png)
